Avant Bio — 2024 Investments
2 investments dated 2024 · listed companies and verified rows first · show all
A stem cell tools and technology company providing standardized platforms to accelerate regenerative medicine development and clinical trials.
BiotechFrederick, US
Jon Rowley(Director)Timothy Kelly(Executive Officer, Director)Margot Connor(Executive Officer, Director)Uplaksh Kumar(Chief Operating Officer)
BoardMartin Westberg(Director)Rob Carlson(Director)
Board seatDaniella Kranjac· per SEC Form D · $12M raise · filed Jul 2024
Co-investorsDynamk CapitalMaryland TEDCOTEDCOVanedge CapitalVanedge Capital Limited Partnership
Virica develops small-molecule cell enhancers called Viral Sensitizers (VSE) that temporarily reduce host cell defenses to increase viral vector yields, quality, and scalability during production.
Advanced ManufacturingBiotechHealthtechOttawa
Board seatDaniella Kranjac· per SEC Form D · filed May 2024
Co-investorsDynamk Capital
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.